Will an Apple a day keep Micro$oft away? Will Facebook outpace MySpace in the war for social networking advertising dollars? And what is Google doing to blow away the Yahooligans? Read our wired-in reporters coverage of the industry that was once thought of as the darling of the baby boomers but now captures the attention of the Gen-Xers. Stop by daily for a dose of HWS insight about innovations in emerging tech stocks.
BWEN – Trading and Chart Update
Two days ago on Monday, Dec.21, I wrote about one of our featured companies, Broadwind Energy, Inc.:
“I am very much intrigued by a longer term view on the chart. A line drawn from September 2, 2008 at $18.50 to touch the July 7, 2009 top at $12.49 and continued down to today’s date [...]
Lithium and AMLM
Recently, one of our featured companies, American Lithium Minerals [ticker symbol:AMLM] experienced volatile trading activity. Since July 17, the stock price has gone from $0.41 to a high on October 22 of $2.99, and just yesterday closed at $0.84.. Certainly after the initial run-up to $2.99 a certain retracing was to be expected. But just [...]
AlphaRx’s Newly Appointed President of China Operations Unveils Strategic Corporate Initiatives
HONG KONG — (MARKET WIRE) — 12/21/09
AlphaRx Inc.’s (OTCBB: ALRX) recently appointed President of China Operations, Ruby Hui, today announced new corporate initiatives and the company’s strategic growth plan for China.
“When I was appointed as the President of AlphaRx China Operations a week ago, I promised that I would play a major part in AlphaRx’s [...]
AlphaRx Signs Contract Manufacturing Agreement for ARX1088
Hong Kong – December 17, 2009 – AlphaRx Inc. (OTCBB: ALRX) announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be [...]
AlphaRx Appoints President for its China Operations
“The Company is poised to become a leading drug developer in the pharmaceutical market in China and I’m looking forward to playing a major part in AlphaRx’s future and driving this company to new heights …”
Hong Kong – December 14, 2009 – AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology [...]
Dynasil Announces the Nominations of Dr. Michael Joyner of the Mayo Clinic and Mr. David Kronfeld of JK & B Capital as New Directors
Dynasil Corporation of America (OTCBB:DYSL.OB), a rapidly growing manufacturer of specialized instruments, detectors and products with applications in homeland security/defense, cancer detection, medical and industrial, today announced that Dr. Michael Joyner of the Mayo Clinic and Mr. David Kronfeld of JK&B Capital of Chicago have been nominated for election to the Dynasil Board of Directors [...]
AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai
Markham, Canada (December 3, 2009) – AlphaRx Inc. (OTCBB: ALRX), today announced that it has selected locations in Hong Kong and Shanghai for its corporate headquarters and a new R&D facility respectively. This initiative will spearhead a major push into Greater China.
The R&D facility will be located in The State Biotech Pharmaceutical industrial base (Shanghai) [...]
